References
- Eriksson J, Fenyö D. Modeling experimental design for proteomics. Methods Mol Biol. 2010;673:223–230. doi: 10.1007/978-1-60761-842-3_14
- Fisher RA. The design of experiments. Edinburgh: Oliver and Boyd; 1935.
- Oberg AL, Vitek O. Statistical design of quantitative mass spectrometry-based proteomic experiments. J Proteome Res. 2009;8(5):2144–2156. doi: 10.1021/pr8010099
- Podwojski K, Stephan C, Eisenacher M. Important issues in planning a proteomics experiment: statistical considerations of quantitative proteomic data. Methods Mol Biol. 2012;893:3–21. doi: 10.1007/978-1-61779-885-6_1
- Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet. 2002;32(Suppl):490–495. doi: 10.1038/ng1031
- Dowell JA, Wright LJ, Armstrong EA, et al. Benchmarking quantitative performance in label-free proteomics. ACS Omega. 2021;6(4):2494–2504. doi: 10.1021/acsomega.0c04030
- Mertins P, Yang F, Liu T, et al. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol & Cell Proteomics. 2014;13(7):1690–1704. doi: 10.1074/mcp.M113.036392
- Gaither C, Popp R, Zahedi RP, et al. Multiple reaction monitoring-mass spectrometry enables robust quantitation of plasma proteins regardless of whole blood processing delays that May occur in the clinic. Mol & Cell Proteomics. 2022;21(5):100212. doi: 10.1016/j.mcpro.2022.100212
- Huang T, Staniak M, da Veiga Leprevost F, et al. Statistical detection of differentially abundant proteins in experiments with repeated measures designs and isobaric labeling. J Proteome Res. 2023;22(8):2641–2659. doi: 10.1021/acs.jproteome.3c00155
- Clough T, Thaminy S, Ragg S, et al. Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs. BMC Bioinf. 2012;13(Suppl16):S6. doi: 10.1186/1471-2105-13-S16-S6